INVESTIGATIONS ON CLINICAL VALIDATION OF MUTATED ZNF208 AS A NOVEL BIOMARKER OF BLAST CRISIS IN CHRONIC MYELOID LEUKEMIA. (2024). Journal of Population Therapeutics and Clinical Pharmacology, 31(9), 1502-1518. https://doi.org/10.53555/68zhqm37